Cordova C, Musca A, Violi F, Alessandri C, Ferro D, Piromalli A, Balsano F
Haemostasis. 1984;14(2):218-22. doi: 10.1159/000215059.
Prekallikrein (Prekk), antithrombin III (ATIII), plasminogen and alpha 2-antiplasmin were evaluated in chronic active hepatitis and in liver cirrhotic patients and correlated with Normotest. Prekk, ATII and plasminogen were significantly decreased in chronic active hepatitis as well as in liver cirrhosis. Alpha 2-antiplasmin levels in chronic active hepatitis patients did not differ from controls; liver cirrhotic patients, on the contrary, showed significantly low values of alpha 2-antiplasmin, Prekk, ATIII and plasminogen were significantly correlated with Normotest in both groups, but when cirrhotic patients were divided into the compensated and decompensated state only Prekk was correlated with Normotest in the decompensated state. The investigation seems to suggest that Prekk could be a reliable index for protein liver failure.
对慢性活动性肝炎患者和肝硬化患者的前激肽释放酶(Prekk)、抗凝血酶III(ATIII)、纤溶酶原和α2-抗纤溶酶进行了评估,并与正常凝血酶原时间试验(Normotest)进行了相关性分析。慢性活动性肝炎患者以及肝硬化患者的Prekk、ATII和纤溶酶原均显著降低。慢性活动性肝炎患者的α2-抗纤溶酶水平与对照组无差异;相反,肝硬化患者的α2-抗纤溶酶值显著降低,两组中Prekk、ATIII和纤溶酶原与正常凝血酶原时间试验均显著相关,但将肝硬化患者分为代偿期和失代偿期时,仅失代偿期的Prekk与正常凝血酶原时间试验相关。该研究似乎表明,Prekk可能是肝衰竭的一个可靠指标。